Central Serous Chorioretinopathy Latest Advances
Find the Latest Research About Central Serous Chorioretinopathy
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2810 publications
Bilateral Giant Pigment Epithelial Detachments and Unilateral RPE Tear and Exudative Retinal Detachment After Tadalafil Exposure: Case Report and Review of the Literature.
Journal: Retinal cases & brief reports
Published: June 22, 2026
Mid-Phase Hyperfluorescent Plaques as a biomarker of disease activity in Central Serous Chorioretinopathy: Clinical Course and Treatment Response - MICRoN report number Ten.
Journal: Retina (Philadelphia, Pa.)
Published: June 22, 2026
GWAS Meta-analysis Identifies Novel Associated Loci and Points to Causal Tissues in Central Serous Chorioretinopathy.
Journal: medRxiv : the preprint server for health sciences
Published: June 04, 2026
Two-Hit Mechanism of a Massive Retinal Pigment Epithelium Tear in Hypertensive Choroidopathy Superimposed on Chronic Central Serous Chorioretinopathy.
Journal: Journal of vitreoretinal diseases
Published: June 04, 2026
Steroidome Dysregulation and Complement C4 Copy Number Variation in Men With Central Serous Chorioretinopathy.
Journal: Investigative ophthalmology & visual science
Published: June 03, 2026
Hyperreflective Band in Shaggy Photoreceptor Outer Segments in Central Serous Chorioretinopathy.
Journal: Retina (Philadelphia, Pa.)
Published: June 03, 2026
Widefield Analysis of Choroidal Vascular Characteristics in Central Serous Chorioretinopathy With Different Choroidal Vein Drainage System.
Journal: Translational vision science & technology
Published: May 27, 2026
Eye on the Eclipse: Demographic Trends in Solar Retinopathy From 2012 to 2024.
Journal: Journal of vitreoretinal diseases
Published: May 21, 2026
Comparison between thin and thick choroid eyes in central serous chorioretinopathy.
Journal: Retina (Philadelphia, Pa.)
Published: May 05, 2026
Outcomes of Treatment for Central Serous Chorioretinopathy With Half-Fluence, Half-Dose Photodynamic Therapy.
Journal: Journal of vitreoretinal diseases
Published: May 01, 2026
Last Updated: 06/30/2026